Insight

Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Collage photo of Marco Ruella and Ruchi Patel

Jul 21, 2024, 21:50

Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Marco Ruella, Assistant Professor Of Medicine and Scientific Director Lymphoma Program at the University of Pennsylvania, shared a post on X about a recent paper by Ruchi Patel et al. published in Science Immunology, commenting:

“Congrats to the now Dr. Ruchi Patel for the publication of her PhD thesis in Science Immunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models.”

“CD5 deletion enhances the antitumor activity of adoptive T cell therapies”

Authors: Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang, Patrizia Porazzi, Marco Ruella et al.

Source: Marco Ruella/X

Aasha Gupta cancer CART immunotherapy Guido Ghilardi liquid cancer models Marco Ruella Nicholas Siciliano Olga Shestova OncoDaily Oncology Ositadimma Ugwuanyi Patrizia Porazzi Puneeth Guruprasad Raymone Pajarillo Ruchi Patel Science Immunology solid cancer models University of Pennsylvania Yi-Hao Chiang Yong Gu Lee Yunlin Zhang

Melanie Griffith and Skin Cancer: How She Went Against, How She Survived, and More

New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression

Gemma Peters: Heading into 2025 with hope

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Special Coverage